Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLloyds Regulatory News (LLOY)

Share Price Information for Lloyds (LLOY)

Share Price is delayed by 15 minutes
Get Live Data
98.90    -1.20 (-1.20%)
Bid:
99.22
Ask:
99.28
Spread: 0.06 (0.06%)
Market Cap: £57.64b
LLOY Live PriceLast checked at - London Stock Exchange

Intraday Lloyds Share Chart

Board Change

5 Jun 2025 12:20

RNS Number : 6476L
Lloyds Banking Group PLC
05 June 2025
 

5 June 2025

LLOYDS BANKING GROUP: BOARD CHANGE

Lloyds Banking Group plc (the "Group") is pleased to announce the appointment of Chris Vogelzang as an independent Non-Executive Director and a member of the Responsible Business Committee, in each case with effect from 16 June 2025.

BIOGRAPHICAL DETAILS

Chris has extensive experience in retail and commercial banking. He possesses a strong understanding of technology's role in financial services and has a track record of driving transformation within organisations.

Chris was Chief Executive Officer of Danske Bank A/S from 2019 until 2021. He held a number of senior positions at ABN AMRO between 2000 and 2016, including Managing Board member with responsibility for Retail and Private Banking, Chief Executive Officer of Retail Banking for The Netherlands and Chief Executive Officer of Global Private Banking.

Chris is currently a Non-Executive Director and a member of the Audit Committee of Wolters Kluwer N.V., which is listed on Euronext Amsterdam, and a senior advisor (financial services) to Boston Consulting Group and to The Blackstone Group.

There is no other information to be disclosed under UK Listing Rule 6.4.8R.

- END -

For further information:

Investor Relations

Douglas Radcliffe

Group Investor Relations Director

Email: douglas.radcliffe@lloydsbanking.com

 

Group Corporate Affairs

Matt Smith

Head of Media Relations

Email: matt.smith@lloydsbanking.com

 

+44 (0) 20 7356 1571

 

 

 

+44 (0) 7788 352 487

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPKPBDDBKDCAK
Date   Source Headline
3rd Jun 20266:08 pmRNSTransaction in Own Shares
2nd Jun 20265:59 pmRNSTransaction in Own Shares
2nd Jun 202611:52 amRNSConsent Solicitation Results Announcement
1st Jun 20266:17 pmRNSTransaction in Own Shares
29th May 20266:11 pmRNSTransaction in Own Shares
29th May 20263:35 pmRNSTotal Voting Rights
29th May 20262:00 pmRNSDirector/PDMR Shareholding
28th May 20266:21 pmRNSTransaction in Own Shares
27th May 20266:03 pmRNSTransaction in Own Shares
26th May 20266:16 pmRNSTransaction in Own Shares
26th May 20262:00 pmRNSDirector/PDMR Shareholding
26th May 20267:00 amRNSBlock Admission Application
22nd May 20266:04 pmRNSTransaction in Own Shares
22nd May 20262:00 pmRNSDirector/PDMR Shareholding
21st May 20266:08 pmRNSTransaction in Own Shares
20th May 20266:12 pmRNSTransaction in Own Shares
19th May 20266:16 pmRNSTransaction in Own Shares
18th May 20266:17 pmRNSTransaction in Own Shares
15th May 20266:13 pmRNSTransaction in Own Shares
14th May 20266:09 pmRNSTransaction in Own Shares
14th May 20261:46 pmRNSResult of AGM
14th May 20268:51 amRNSAdmission to Trading
13th May 20266:24 pmRNSTransaction in Own Shares
13th May 20262:00 pmRNSDirector/PDMR Shareholding
12th May 20266:06 pmRNSTransaction in Own Shares
12th May 20262:20 pmRNSPublication of Final Terms
12th May 20269:18 amRNSFinal Terms
11th May 20266:20 pmRNSTransaction in Own Shares
11th May 20268:37 amRNSConsent Solicitation Launch Announcement
11th May 20268:31 amRNSNotice of Meeting
8th May 20266:19 pmRNSTransaction in Own Shares
7th May 20265:55 pmRNSTransaction in Own Shares
6th May 20266:13 pmRNSTransaction in Own Shares
5th May 20265:52 pmRNSTransaction in Own Shares
5th May 20262:00 pmRNSDirector/PDMR Shareholding
1st May 20266:12 pmRNSTransaction in Own Shares
1st May 20262:00 pmRNSAdmission to Trading
30th Apr 20266:28 pmRNSTransaction in Own Shares
30th Apr 20264:37 pmRNSTotal Voting Rights
30th Apr 202612:40 pmRNSPublication of a Supplementary Prospectus
30th Apr 202610:29 amRNSPublication of a Supplementary Prospectus
30th Apr 202610:23 amRNSPublication of a Supplementary Prospectus
30th Apr 202610:08 amRNSNotification of Redemption
29th Apr 20266:06 pmRNSTransaction in Own Shares
29th Apr 202612:56 pmRNS2026 Q1 Interim Management Statement
29th Apr 20267:00 amRNS2026 Q1 Interim Management Statement
28th Apr 20266:07 pmRNSTransaction in Own Shares
27th Apr 20266:13 pmRNSTransaction in Own Shares
24th Apr 20266:02 pmRNSTransaction in Own Shares
23rd Apr 20265:54 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.